Fig. 6From: Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancerComparison of effective doses for typical administered activities for various GRPR- and PSMA-targeted compounds. a [23]; b [33]; c [34]; d [35]; e [36]; f [37]Back to article page